BIO International 2018 in Boston June 4-7. I see Resverlogix and Zenith on the schedule. Maybe in the next month DM can manage to make at least one new slide. Zing! I'll be very surprised if we don't hear about the SSRA before then. At least we expect something about the TSX de-listing review (May 14th currently) or closing of financing(s).

http://convention.bio.org/uploadedFiles/BIO2018_SampleAttendeeList.pdf

Some athero/lipid/renal conferences happening between now and then. So far, I haven't found any indication that Resverlogix is presenting. Possibly they will be attending. EAS Congress in Portugal May 5-8, Vascular Discovery in San Francisco May 9-12 (including HDL workshop), ERA-EDTA, in Denmark May 24-27 (including Epigenetics/CKD/CVD Symposium).

BearDownAZ